You searched for "Prostate"

569 results found

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

Mermaid Medical: Transperineal Prostate Biopsy with TP Pivot Pro™ webinar

With Dr. Dimitrios Papadopoulos, MD Robotic Surgeon & Urological Consultant specialising in precision, minimally invasive prostate care and advanced image-guided biopsy techniques.

New analysis by Prostate Cancer UK uncovers inequalities in mortality and refutes prevailing beliefs

Prostate cancer mortality rates continue to be higher in Black men than white men, latest analysis reports. The disparity persists across all levels of deprivation, challenging beliefs that socioeconomic differences alone explain ethnic differences in outcomes. Even in the least...

Announcing a new specialist distributor of medical devices for prostate cancer

Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

FUJIFILM Healthcare Europe launches a dedicated prostate fusion imaging platform

FUJIFILM Healthcare Europe is pleased to have unveiled the ARIETTA™ 65 IntuitiveFusion.

Erection pills may improve heart conditions and diabetes but are underused – Prostate Cancer UK research

More than 80% of men affected by prostate cancer experience erection problems. Research in the World Journal of Men’s Health, led by Prostate Cancer UK, shows evidence that erection medication can also improve serious conditions including stroke, diabetes and enlarged...

Prostate Scotland launches new research project into BPE with support from the Grand Lodge of Scotland

Prostate Scotland has launched a new two-year research project into benign prostatic enlargement (BPE), thanks to long-term funding support from The Grand Lodge of Scotland and Scottish Freemasons. The project aims to build a clearer picture of the experiences of...

The Royal Marsden: Demystifying the Science Behind Targeted Treatments and Immunotherapies for Prostate, Bladder & Kidney Cancers Study Day

Dr Elaine Vickers will provide an introduction to the science behind a wide variety of targeted therapies and immunotherapies given to people with prostate, bladder and kidney cancer.

Prostate Cancer UK announced as official charity partner for MOBO Awards

The stage is set! Global dancehall queen Spice, UK rap kings Krept and Konan and the multi-talented Bashy are the first wave of performers announced to ignite the stage at the 2025 MOBO Awards.

Wit, wine, whisky and wisdom – Prestonfield’s Burns Supper returns for 2026 in aid of Prostate Scotland

Tickets are now on sale for Prestonfield’s annual Burns Supper, taking place on Thursday 22 January 2026 at the spectacular Prestonfield House in Edinburgh. This enchanting evening promises an opulent blend of wit, wine, whisky and wisdom, all in support...

New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals

A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...